TRPV1 and arthritic joint disease: In rats with complete Freund's adjuvant‐induced arthritis, intrathecal injection of a Nogo‐A receptor antagonist has been shown to reduce the TRPV1 content in the DRG and effectively relieve chronic pain [24].